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Abstract
Background: It has previously been shown that low back pain (LBP) often presents already in the
teenage years and that previous LBP predicts future LBP. It is also well documented that there is a
large degree of comorbidity associated with LBP, both in adolescents and adults. The objective of
this study is to gain a deeper insight into the etiology of low back pain and to possibly develop a
tool for early identification of high-risk groups. This is done by investigating whether different types
of morbidity in adolescence are associated with LBP in adulthood.
Methods: Almost 10,000 Danish twins born between 1972 and 1982 were surveyed by means of
postal questionnaires in 1994 and again in 2002. The questionnaires dealt with various aspects of
general health, including the prevalence of LBP, classified according to number of days affected
during the previous year (0, 1–7, 8–30, >30). The predictor variables used in this study were LBP,
headache, asthma and atopic disease at baseline; the outcome variable was persistent LBP (>30 days
during the past year) at follow-up. Associations between morbidity in 1994 and LBP in 2002 were
investigated.
Results: LBP, headache and asthma in adolescence were positively associated with future LBP.
There was no association between atopic disease and future LBP. Individuals with persistent LBP
at baseline had an odds ratio of 3.5 (2.8–4.5) for future LBP, while the odds ratio for those with
persistent LBP, persistent headache and asthma was 4.5 (2.5–8.1). There was a large degree of
clustering of these disorders, but atopic disease was not part of this pattern.
Conclusion: Young people from 12 to 22 years of age with persistent LBP during the previous
year have an odds ratio of 3.5 persistent LBP eight years later. Both headache and asthma are also
positively associated with future LBP and there is a large clustering of LBP, headache and asthma in
adolescence.
Background
Chronic low back pain (LBP) is a major socio-economic
burden for both society and individuals. In Denmark,
musculo-skeletal disorders, of which LBP was the most
common, was the reason for 50% of all disorders, classi-
fied as "work-related", in the year of 2000 [1]. In 2002, it
was the second-most common reason for disability pen-
sion, responsible for 22% of all disability pensions [1].
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Furthermore, the cost of long-term sick leave due to mus-
culo-skeletal disorders increased from 1987 to 2000 in
Denmark [2].
Unfortunately, we are unable to predict chronic LBP at an
early stage. Several risk factors for chronicity, such as psy-
chological distress or depressive mood [3], poor general
health [4-6], and work-related factors [7,8], have been
identified. These findings are based on studies of adult
patient-populations, although it has been shown that
more than half of the population experience their first
attack of LBP before the age of 20 [9]. Thus, studies of
adults are not likely to include inception cohorts and their
results cannot be used to aid in the design of primary pro-
phylactic efforts. Therefore, we find it important to shift
focus from risk factors associated with LBP in adult life to
early predictors for LBP. Both our group and others have
previously shown LBP in adolescence to be a major pre-
dictor for later LBP [10-12]. Our group has also demon-
strated strong cross-sectional associations between LBP in
adolescence and the presence of various other diseases
[13]. This investigation aims to investigate how LBP and
other diseases in young people are associated with later
persistent LBP.
Methods
Data sources
The Danish Twin Register is the most comprehensive pop-
ulation based twin register in the world, spanning a
period of more than 100 years. The twins of interest for
this study were born between 1972 and 1982. They were
identified through the Danish civil registration system
and represent 95% of the twins born during that period.
These twins can be regarded as representative of the gen-
eral population since they have the same mortality rate
[14] and the same prevalence of various diseases as the
population at large, such as insulin dependent diabetes
[15], hand eczema [16], asthma and allergic rhinitis [17],
and LBP [18]. Details about ascertainment etc. are pro-
vided elsewhere [19]. In 1994, when the twins were 12 to
22 years old, comprehensive questionnaires were sent to
those twins who previously had agreed to participate in
future studies (96%). The questionnaires contained ques-
tions on disease, health and health-related behaviour.
Similar questionnaires were sent to the same population
in 2002, when they were 20–30 years of age. The out-
come-variable of interest for this paper was the number of
days with LBP during the year prior to follow-up. The
same variable at baseline was used as one of the covari-
ates. The exact wording of the question was: "How many
days have you altogether had trouble with the lower part of
your back during the past year?". The additional, relevant
information was based on the following questions: Have
you ever had any of the following: diabetes, asthma,
atopic dermatitis, hay fever, wheezing respiration from
colds, exertion, or from contact with animals or pollen,
shortness of breath when walking, long periods (> a
month) with cough and phlegm, dry cough not connected
to colds, juvenile rheumatoid arthritis, rheumatoid arthri-
tis, migraine, headache with nausea, headache associated
with photophobia/phonophobia, temporary visual
impairment followed by headache, or severe ocular pain.
The respondents also reported number of days with head-
ache during the past year. The exact wording is available
from the authors. Validation: The questions regarding LBP
were modelled on the Nordic Back Pain questionnaire
[20], which has been validated previously [21]. In a previ-
ous study, analyses of validity were performed on the data
from the 1994-omnibus by cross-tabulating LBP-days
with LBP-ever and found to be satisfactory [13]. Similarly,
the reliability of LBP-questions from the 2002-omnibus
has previously been considered to be satisfactory through
identification of logical errors [10].
Representativeness
Responders and non-responders at follow-up were com-
pared with regard to age, gender, LBP-status and all the
covariates at baseline.
Variables
Number of days with LBP during the past year was trans-
formed into persistent LBP ('LBP-long'), defined as LBP
for more than 30 days during the previous year, and LBP
at all ('LBP-all'), defined as LBP for one day or more dur-
ing the previous year. Persistent (or recurrent) LBP is the
most interesting outcome variable, both from a socio-eco-
nomic perspective and from an individual's perspective,
since brief/transient episodes of LBP do not influence the
professional or the social life of the person to any large
extent. Therefore, we chose persistent LBP ('LBP-long') as
outcome variable.
Because the focus of this investigation is on self-reported
symptoms, the covariates were grouped into three broad
categories of symptoms:
• The first group covers those with asthma-like symptoms
with or without a diagnosis of asthma ('asthma'): It con-
sists of those who reported having at least one of the fol-
lowing: asthma, wheezing breath from colds, exertion, or
from contact with animals or pollen, shortness of breath
when walking, long periods (> a month) with cough and
phlegm, and dry cough not connected to colds.
• The second group includes people with possible atopic
disease, but no evidence of asthma ('atopic disease'), and
consists of those who answered that they had atopic der-
matitis and/or hay fever, but without asthma. It should be
noted that according to these definitions asthma and
atopic disease do not overlap.BMC Musculoskeletal Disorders 2006, 7:29 http://www.biomedcentral.com/1471-2474/7/29
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• The third group covers all types of headache, regardless
of etiology ('headache') and includes those who answered
positively to at least one of the following: migraine, head-
ache with nausea, headache with photophobia/phono-
phobia, temporary visual impairment followed by
headache, severe ocular pain. Finally, the respondents
noted the number of days with headache the past year.
Analog to LBP, this was transformed into persistent head-
ache ('headache-long'), defined as headache for more
than 30 days during the previous year, and headache at all
('headache-all'), defined as headache for one day or more
during the previous year.
There were a total of 26 individuals (0.3%) with diabetes
and 30 (0.3%) with rheumatoid arthritis at baseline.
Thus, both diabetes and rheumatoid arthritis were too
rare to do any meaningful analyses and were not analysed
further.
Analyses
The associations between the outcome variable and the
individual independent variables (asthma, atopic disease,
headache and LBP) were investigated through bivariate
logistic regression analyses. Confidence intervals of 85%
were used to decide inclusion or exclusion in the multivar-
iate analyses, since a statistical significance of 0.05 is too
stringent. Variables meeting this cut-off point may still
influence the effect of the other variables. Since the preva-
lence of LBP increases with age and is higher in females,
age and sex were forced into all models.
Thereafter, those variables found to be statistically signifi-
cant at the 0.15-level in the bivariate analyses were cross-
tabulated to assess the size of the subgroups and the com-
binations between disorders. The same variables were
then included in multivariate logistic regression analyses.
Possible interactions between predictor-variables were
investigated, which was possible because of the large sam-
ple size. Odds ratios were calculated for two models: one
including the more lenient definitions of LBP and head-
ache and another including the persistent types of LBP
and headache. Age and gender were forced into the mod-
els and if they were significant, they were removed from
the model and results were stratified instead. Finally, to
gain an overview of the practical value of the results, prev-
alence estimates of persistent LBP at follow-up were pre-
sented for the relevant subgroups.
Post-hoc analyses: Due to concern that "atopic disease"
might mask a possible effect of one the two disorders
(atopic dermatitis and hayfever), separate bivariate analy-
ses were performed for these two disorders.
Table 1: Description of sample and comparison of baseline- and follow-up-sample.
Baseline Follow-up
Responders, n (%) 9,600 (84%) 6,554 (57% of the original sample, 68% of the baseline sample)
Age at baseline, mean (range) 17.27 (11–22) 17.38 (11–22)
Female/male, n (%) 4,946 (52%)/4,654 (48%) 3,682 (56%)/2,868 (44%)
LBP-long 1994 (LBP>30 days past year), n (%) 588 (6%) 401 (6%)
LBP-all 1994 (LBP>0 days past year), n (%) 3,223 (34%) 2,322 (35%)
Number of days with LBP 1994, mean (SD) 10.46 (38.37) 10.80 (38.78)
Headache-long 591 (7%) 414 (7%)
Headache-all 8.266 (86%) 5.635 (86%)
Asthma 2.685 (28%) 1.785 (27%)
Atopic disease 998 (10%) 707 (11%)
Table 2: Bivariate logistic regression analyses of associations between health status at baseline and persistent LBP at follow-up as well 
as prevalence of persistent LBP at follow-up within the respective groups. Age and sex were included in the model.
Morbidity 1994 OR for LBP-long 2002 (95%/85% 
confidence interval)
Prevalence of LBP-long 2002 (95% 
confidence interval)
LBP-long 3.53 (2.75–4.52)/(2.94–4.23) 26% (22–31%)
LBP-all 1.98 (1.67–2.36)/(1.75–2.25) 14% (12–15%)
Headache-long 2.12 (1.62–2.79)/(1.74–2.59) 20% (16–24%)
Headache-all 1.56 (1.17–2.08)/(1.26–1.93) 10% (10–11%)
Asthma 1.44 (1.21–1.71)/(1.26–1.63) 12% (11–15%)
Atopic disease 1.04 (0.80–1.36) / (0.87–1.27) 10% (8–13%)
All Not applicable 10% (9–10%)BMC Musculoskeletal Disorders 2006, 7:29 http://www.biomedcentral.com/1471-2474/7/29
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All analyses were done using the STATA 8.0 statistical soft-
ware package. The cluster-option as provided by STATA
was applied to account for dependency between twins and
p-values of 0.05 or less were considered to be significant.
Results
Study sample and representativeness
The study sample is described in Table 1 for both baseline
and the 8-year follow-up. The age distribution was the
same for responders and non-responders, but there were
4% more females at follow-up than in the baseline sam-
ple. There were no differences between the baseline sam-
ple and the follow-up sample with regard to the
prevalence estimates of LBP, headache, asthma or atopic
disease.
Bivariate analyses
The bivariate analyses (with age and sex included in the
model) showed all the potential predictor variables to be
statistically significantly associated with persistent LBP at
follow-up, with the exception of atopic disease. The
strongest predictors were persistent LBP and persistent
headache at baseline. The exact estimates are shown in
Table 2.
To investigate whether the associations between a certain
disorder and future LBP was merely a measure of this dis-
order's association with LBP at baseline (bearing in mind
the predictive value of LBP on future LBP), we repeated
the bivariate analyses in a subsample excluding the 588
individuals with persistent LBP at baseline (Table 3).
The estimates were almost the same as for the whole
group, indicating some degree of increased risk associated
with headache and asthma, despite LBP-status. There were
no associations between atopic disease in youth and later
LBP, and the prevalence of LBP, headache and asthma
were not statistically different between subjects with and
without atopic disease (p = 0.123–0.156). Thus, atopic
disease does not seem to be associated with any of the
other covariates and was not included in the multivariate
analyses.
Description of subgroups
To gain an overview of the various subgroups, the size of
these are listed in Table 4. This shows, that headache is by
far the most common disorder. Comparison of the per-
centages in Table 4 also illustrates the large degree of
comorbidity.
Multivariate analyses
Despite the large overlap between disorders (comorbid-
ity), none of the interaction-terms between the three pre-
dictor-variables (LBP, headache and asthma) were found
to be statistically significant, and therefore the multivari-
ate models were constructed without inclusion of interac-
tions. Age was not significant, whereas there was a positive
association with female gender. Therefore, the results were
stratified for gender. The results of the two models – 1)
one with all types of LBP and headache (LBP-all and head-
ache-all) and 2) one with persistent LBP and headache
(LBP-long and headache-long) – are shown in Table 5.
This illustrates no significant difference between the two
sexes, but significantly higher odds ratios in the model
containing the persistent disorders. For the combination
Table 3: Bivariate logistic regression analyses of associations between health status at baseline and LBP at follow-up as well as 
prevalence of persistent LBP at follow-up within the respective groups. Based on a sample excluding individuals with persistent LBP at 
baseline. Age and sex were included in the model.
Morbidity 1994 OR for LBP-long 2002 (95% CI) Prevalence of LBP-long 2002 (95% CI)
Headache-long 2.52 (1.56–4.07) 14% (9–21%)
Headache-all 1.40 (1.04–1.88) 9% (8–10%)
Asthma 1.34 (1.10–1.62) 11% (9–12%)
Atopic disease 1.08 (0.82–1.43) 9% (7–12%)
All NA 9% (8–9%)
Table 4: Cross-tabulation of the independent baseline-variables (n = 9,600). Percentages calculated across rows (i.e. within diagnostic 
subgroups).
n (% of total sample) LBP LBP-long Headache Headache-long Asthma
LBP-all 3,223 (34%) 588 (18%) 2,974 (92%) 334 (10%) 1,244 (39%)
LBP-long 588 (6%) 588 (100%) 559 (95%) 134 (23%) 287 (49%)
Headache-all 8,266 (86%) 2,974 (36%) 559 (7%) 591 (7%) 2,446 (30%)
Headache-long 591 (6%) 334 (57%) 134 (23%) 591 (100%) 269 (46%)
Asthma 2,685 (28%) 1,244 (46%) 287 (11%) 2,446 (91%) 269 (10%)BMC Musculoskeletal Disorders 2006, 7:29 http://www.biomedcentral.com/1471-2474/7/29
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of persistent LBP, persistent headache and asthma the
odds ratio is 4.5 (2.5–8.1). If asthma is ignored, the odds
ratio is similar: 4.6 (2.9–7.4). Of the 86 individuals with
both persistent LBP and persistent headache, 50 (58%)
also have asthma.
Prevalence of persistent LBP at follow-up for the various 
subgroups
To illustrate the increasing prevalence of LBP, as the sub-
jects' morbidity increases, we calculated the prevalence of
persistent LBP in the various subgroups of baseline-mor-
bidity. The overall one-year prevalence of persistent LBP
in 2002 was 10%. For those with no LBP in 1994, the one-
year prevalence of persistent LBP in 2002 was 7%, for
those with any LBP at all 8 years previously, it was 14%,
and if this LBP was persistent, the prevalence was 26%. If
the persons in addition to persistent LBP in 1994 also suf-
fered from headache, the resulting one-year prevalence of
persistent LBP at follow-up was 27%, and if this headache
was long-lasting, the corresponding prevalence was 36%.
This stepwise effect is illustrated in Figure 1.
Post-hoc analyses
Post-hoc analysis of the association between atopic der-
matitis at baseline and persistent LBP at follow-up
revealed an odds ratio of 0.99 with an 85% confidence
interval of 0.93 to 1.05. Similar analysis of hayfever gave
an odds ratio of 1.04 with an 85% confidence interval of
0.98 to 1.10. Thus, none of these two conditions were
included in the multivariate analyses.
Discussion
The major strengths of our cohort are the large sample size
and the age of the subjects. Monitoring the health of such
a large sample from adolescence into adulthood can pro-
vide much needed clues to early prevention. Furthermore,
the cohort is representative of the total Danish population
and can be followed also in future years. As mentioned
earlier, LBP has previously been shown to be a strong pre-
dictor for future LBP [10-12] and associations between
LBP and various other disorders have often been shown
[4-6]. However, we are not aware of any other studies
investigating how other aspects of health in young popu-
lations are associated with later LBP.
Unfortunately, the response rate fell to 68% at follow-up,
probably due to a large increase in the length of the ques-
tionnaire. A comparison of responders and non-respond-
ers shows a somewhat higher proportion of females at
follow-up, but no differences in the independent or the
dependent variables. Therefore, the lower response rate is
unlikely to have any bearing on our results, when strati-
fied for gender.
We found LBP, headache and asthma to be statistically
significant predictors for future persistent LBP in bivariate
analyses with persistent LBP demonstrating by far the
strongest association. The multivariate analyses showed
that there was in fact a statistically significant effect of all
three disorders, meaning that the results from the bivari-
ate analyses were not just a result of baseline-comorbidity.
The estimated odds ratio for persistent LBP at follow-up
was higher if the individual had LBP-long, headache-long
and asthma than if only LBP-long was included in the
model (4.5 vs. 3.5), but this difference was not statistically
significant and at the same time, by reducing the size of
the high-risk group, the number of identified cases was
strongly reduced. Therefore, as a screening tool, simply
asking about LBP is more efficient than to include all three
variables in this question. Although persistent LBP is the
strongest predictor, we do not know whether LBP is the
key etiological issue, and therefore cannot conclude that
comorbidity does not matter. With the large degree of
clustering of disorders in some individuals, it is possible
that some other underlying factor is the main reason
behind the predictive value of LBP. The large overlap of
disorders, but no effect-modification (interaction) at
baseline, could indicate some common cause for the var-
ious disorders. There could be some underlying frailty,
rendering some individuals more susceptible to various
Table 5: Multivariate logistic regression analyses of associations between health status at baseline and persistent LBP at follow-up. 
Stratified for gender and adjusted for age.
Females OR (95% CI) Males OR (95% CI)
Model 1
LBP-all, n = 3,223 1.78 (1.45–2.23) 2.04 (1.50–2.79)
Headache-all, n = 8,266 1.74 (1.08–2.79) 1.14 (0.78–1.66)
Asthma, n = 2,685 1.36 (1.10–1.69) 1.11 (0.80–1.53)
LBP-all + headache-all + asthma, n = 1,189 1.87 (1.46–2.39) 1.85 (1.25–2.75)
Model 2
LBP-long, n = 588 3.55 (2.60–4.83) 2.54 (1.53–4.20)
Headache-long, n = 591 1.55 (1.13–2.11) 2.40 (1.21–4.74)
Asthma, n = 2,685 1.37 (1.10–1.70) 1.12 (0.80–1.57)
LBP-long + headache-long + asthma, n = 81 4.22 (2.27–7.82) 6.56 (1.19–36.35)BMC Musculoskeletal Disorders 2006, 7:29 http://www.biomedcentral.com/1471-2474/7/29
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disorders. The important aspect of this study is that if such
a frailty exists, it persists into adulthood. Such a 'common
cause' or underlying frailty could be genetically deter-
mined, due to social vulnerability or based on morphol-
ogy, physiology or certain psychological traits. If such a
frailty can be detected early in life, many later problems
might be prevented or diminished.
Obviously, with a prevalence of persistent LBP of only
26% in the subgroup with persistent baseline LBP, this
single variable is a crude predictor. However, as it requires
only one simple question, which could be easily incorpo-
rated in routine medical examinations, we feel it could be
a sensible way to start. Those with persistent LBP at an
early age can then be submitted to close monitoring. This
is a subgroup of only 6% of the entire cohort, with the
remainder of the cohort having a rather low risk (preva-
lence of 9%) and thus, resources could be allocated to a
group with a risk that is much higher than average. The
relevance of this is accentuated, when considering the age
of the cohort – most of them have not yet entered the
workforce. Since some professions are associated with
higher risk of LBP than others [22], an evaluation of a
young person's risk of future LBP should be part of good
career-counselling programmes. However, in this work it
must also be emphasized that despite the significantly
increased odds of future LBP in this group, two thirds of
these 'at risk' did not have persistent LBP at follow-up.
Conclusion
Young people from 12 to 22 years of age with persistent
LBP during the previous year have an odds ratio of 3.5 for
persistent LBP eight years later. Although both headache
and asthma are positively associated with future LBP, add-
ing information about these other disorders does not help
in identifying high-risk groups of persistent LBP. The rea-
son being a large degree of clustering of disorders in these
young individuals. This indicates an underlying frailty or
common cause for the various disorders which continues
into adulthood.
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